Genetic Signatures Ltd has released a press release.
CE-IVD received for COVID-19 test
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- First shipments and regulatory submissions for COVID-19 test
- Pause in Trading
- Appendix 4C & quarterly report
- Investor presentation - capital raise
- Genetic Signatures completes $35m placement
Later from Genetic Signatures
- TGA registration of SARS-CoV-2 detection kit
- Appendix 4C & quarterly update
- S&P DJI Announces June 2020 Quarterly Rebalance
- Quarterly report and Appendix 4C
- Preliminary Final Report
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures